
The aged population is at the greatest risk for cancer and therefore the disease is becoming any ever-increasing problem as human longevity increases. Approximately one half of the common cancers occur in patients over 70. Paradoxically, however, they are excluded from clinical trails on grounds of "frailty". Such data as are available indicated that elderly cancer patients are often undertreated, giving rise to an increased risk of recurrence and death.This book considers the relationship between aging and malignancy and brings together a breadth of international clinical research on cancer in the elderly. The management of common tumors is examined from the perspective of surgery, radiotherapy, and medical oncology. Additionally, the psychosocial problems of the elderly and the specific needs for palliative care in older patients are discussed. Cancer in the Elderly makes recommendations for optimal treatment, but the authors also identify areas where knowledge is scarce and there is a need for both basic and applied research.
This book investigates the clinical challenges and research gaps inherent in treating cancer within the aging population. Author Ian S. Fentiman, a specialist in the field, synthesizes international clinical data to address the paradox of excluding elderly patients from trials due to perceived frailty. The text argues that current undertreatment of this demographic contributes to higher recurrence and mortality rates, advocating for evidence-based management strategies.
What You Will Find
Scope Limits
Experts recognize this work as a significant contribution to geriatric oncology, particularly for its focus on the systemic exclusion of older patients from clinical trials. Readers frequently note the clinical density of the prose, making it a valuable resource for medical practitioners and researchers seeking to improve care standards for the elderly.
Page Count:
173
Publication Date:
1994-01-15
Publisher:
Oxford University Press
ISBN-10:
0192622005
ISBN-13:
9780192622006
No comments yet. Be the first to share your thoughts!